Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2019 Mar;8(Suppl 2):S118-S119.
doi: 10.21037/tcr.2018.11.19.

Impact of breast surgery in de novo stage IV breast cancer

Tadahiko Shien  1
Affiliations
Editorial

Impact of breast surgery in de novo stage IV breast cancer

Tadahiko Shien. Transl Cancer Res. 2019 Mar.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The author has completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/tcr.2018.11.19). The author has no conflicts of interest to declare.

Comment on

References

    1. Fitzal F, Bjelic-Radisic V, Knauer M, et al. Impact of Breast Surgery in Primary Metastasized Breast Cancer: Outcomes of the Prospective Randomized Phase III ABCSG-28 POSYTIVE Trial. Ann Surg 2018. [Epub ahead of print]. 10.1097/SLA.0000000000002771 - DOI - PubMed
    1. Badwe R, Hawaldar R, Nair N, et al. Locoregional treatment versus no treatment of the primary tumour in metastatic breast cancer: an open label randomised controlled trial. Lancet Oncol 2015;16:1380-8. 10.1016/S1470-2045(15)00135-7 - DOI - PubMed
    1. Petrelli F, Barni S. Surgery of primary tumors in stage IV breast cancer: an updated meta-analysis of published studies with meta-regression. Med Oncol 2012;29:3282-90. 10.1007/s12032-012-0310-0 - DOI - PubMed
    1. Soran A, Ozmen V, Ozbas S, et al. Randomized Trial Comparing Resection of Primary Tumor with No Surgery in Stage IV Breast Cancer at Presentation: Protocol MF07-01. Ann Surg Oncol 2018;25:3141-9. 10.1245/s10434-018-6494-6 - DOI - PubMed
    1. Shien T, Nakamura K, Shibata T, et al. A randomized controlled trial comparing primary tumour resection plus systemic therapy with systemic therapy alone in metastatic breast cancer (PRIM-BC): Japan Clinical Oncology Group Study JCOG1017. Jpn J Clin Oncol 2012;42:970-3. 10.1093/jjco/hys120 - DOI - PubMed